Milan, Italy (September 20, 2023)
Today, MgShell, a MedTech company that aspires to inspire a change in ophthalmology by developing a magnesium-based drug delivery platform capable of reshaping patient care and enhancing treatment adherence for patients suffering from retinal diseases, announced its attendance at the 2023 edition of Stage Two.
MgShell is proud to announce its nomination by PoliHub-Innovation Park & Startup Accelerator to pitch at Stage Two, the largest pan-European competition for the best startups spinning out of leading universities. Behind Stage Two is a network of 40+ of Europe’s top universities, which follow the vision to connect top universities, the startups of tomorrow, industry leaders, and VC across national borders.
MgShell is excited and looking forward to representing Politecnico di Milan at Stage Two, taking place on October 19, 2023 in Berlin.
If you don’t want to miss it, you can participate online at the event on October 19, 2023 via the free live stream after the registration at the following link.
About MgShell:
MgShell, headquartered in Milan, Italy, is a preclinical stage drug delivery company focused on developing a magnesium-based drug delivery platform capable of reshaping patient care, enhancing treatment adherence for patients suffering from retinal diseases, and lowering healthcare expenses.
